Insights Into Participating in Studies for Bone Cancer

Status Not yet recruiting

Clinical Trial Summary

Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06070259
Study type	Observational
Source	Power Life Sciences Inc.
Contact	Michael B Gill
Phone	4159004227
Email	bask@withpower.com
Status	Not yet recruiting
Phase
Start date	October 2024
Completion date	October 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03905174` - Massive Implants the Next Generation	N/A
Completed	`NCT00160719` - HLA Sensitization Following Major Cortical Allograft Bone Procedures	Phase 4
Completed	`NCT04974008` - Osteosarcoma Maintenance Therapy With OST31-164	Phase 2
Completed	`NCT01553539` - Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery	Phase 2
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Active, not recruiting	`NCT02880319` - Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone	Phase 2
Completed	`NCT01135849` - B-Receptor Signaling in Cardiomyopathy	N/A
Terminated	`NCT00960063` - A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)	Phase 1
Terminated	`NCT02443103` - Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis	N/A
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated	`NCT03525392` - Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.	Phase 1
Terminated	`NCT01541358` - Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer	N/A
Terminated	`NCT01313884` - Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma	Phase 2
Completed	`NCT01091883` - Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma	N/A
Terminated	`NCT00127387` - Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia	Phase 2/Phase 3
Not yet recruiting	`NCT03106675` - MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases	N/A
Recruiting	`NCT05830084` - Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma	Phase 1
Completed	`NCT01085565` - Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System	Phase 2
Recruiting	`NCT04307914` - Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases	N/A
Terminated	`NCT01163539` - Cyberknife Radiosurgery and Quality of Life	N/A